E&C leaders ask MedPAC to examine consolidation

Sep 04, 2018 - 02:43 PM

House Energy and Commerce Committee leaders Aug. 30 sent a letter to the Medicare Payment Advisory Commission asking it to conduct additional research on hospital consolidation and the financial impact it has on Medicare patients and the program. Among other areas, the committee asks MedPAC to examine recent trends in hospital consolidation and the effects on hospitals and patients’ costs; how the integration between physicians and hospitals has affected Medicare payments for physician services; and questions related to the use of the 340B drug savings program. A 2017 study prepared for the AHA by Charles River Associates found that hospital mergers result in efficiencies, savings, innovation and quality improvements essential to transforming health care delivery, all of which benefits patients. The committee asks MedPAC to respond to this request within 30 days.
 

Related News Articles

Headline
Court rules that companies may not impose 340B rebate model without HHS approval
The U.S. District Court for the District of Columbia July 21 upheld a lower court’s decision that Section 340B of the Public Health Service Act does not …
Headline
CMS posts updated FAQ on PAMA clinical laboratory private payer data reporting 
The Centers for Medicare & Medicaid Services has released an updated FAQ on Protecting Access to Medicare Act private payer data reporting. The deadline is…
Headline
Draft guidance released for 2028 cycle of Medicare drug price negotiations 
The Centers for Medicare & Medicaid Services July 16 released draft guidance for the 2028 cycle of negotiations under the Medicare Drug Price Negotiation…
Headline
AHA challenges HRSA’s burden estimate for proposed 340B rebate model
The AHA July 14 urged the Health Resources and Services Administration to revise its estimate of the administrative burden associated with the agency’s…
Headline
AHA urges court to reject AbbVie bid to change 340B program rules
The AHA today filed a friend-of-the-court brief supporting the Department of Health and Human Services’ motion to dismiss AbbVie’s lawsuit …
Headline
HRSA announces 340B program sales reached $100 billion in CY 2025
The Health Resources and Services Administration announced that 340B covered entities purchased $100 billion in outpatient drugs under the federal 340B Drug…